AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Earnings Insights: Weight Loss Drugs and Estee Lauder's Struggles
This chapter analyzes the earnings reports of Eli Lilly and Novo Nordisk, highlighting their stock valuations within the growing GLP-1 drug market. It also discusses Estee Lauder's declining stock price and lowered fair value estimates amidst challenges in the Chinese market.